Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Rajendran

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancerJoseph G Rajendran, David L Schwartz, Janet O'Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumorsDouglas S Hawkins, Scott M Schuetze, James E Butrynski, et al.
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsMark Muzi, Lanell M Peterson, Janet N O'Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imagingJoseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphomaAjay K Gopal, Ted A Gooley, Joseph G Rajendran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancerJoseph G Rajendran, David L Schwartz, Janet O'Sullivan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumorsDouglas S Hawkins, Scott M Schuetze, James E Butrynski, et al.
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsMark Muzi, Lanell M Peterson, Janet N O'Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imagingJoseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphomaAjay K Gopal, Ted A Gooley, Joseph G Rajendran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Pageof 4